Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon
Thumbnail

Universal Health Services CEO was highest-paid hospital leader in 2016

If you were judging hospital executives by their pay, the winner would Alan Miller, MBA, chairman and CEO of Pennsylvania-based Universal Health Services, who earned $51.3 million in 2016.

Online tool expands measurements to predict risk of heart disease, diabetes

Predicting a patient's risk for developing heart disease or diabetes can be like looking into a crystal ball. Such a tool is now an online reality thanks to a team of researchers from the University of Virginia School (UVA) of Medicine and the University of Florida.

Amazon Alexa challenge combines diabetes management, voice technology

The Alexa Diabetes Challenge, launched April 10, is searching for innovators to improve the capabilities of the Amazon Alexa voice-enabled device to assist users with type 2 diabetes. The multi-stage competition, sponsored by Merck & Co. and supported by Amazon Web Services, is offering $250,000 in total in prizes.

Thumbnail

S&P: ACA markets ‘fragile'—but not in death spiral

Despite claims by President Donald Trump, Republican members of Congress, and some insurance CEOs, the Affordable Care Act (ACA)’s health insurance exchanges aren’t in a death spiral, according to a Standard and Poor’s (S&P) analysis, which predicts the individual market is actually on a path to profitability in 2018.

Contacting patients before surgery cuts cancellations in half

Cancelling a preplanned surgery, especially in ambulatory care, costs hospitals money and resources and wastes time. A recent study, published in AORN, looked at how contacting patients by phone before surgery can reduce the number of cancellations. 

FDA OKs 23andMe to sell disease risk genetic tests

In a first for the U.S. Food and Drug Administration (FDA), the genetic testing company 23andMe is being given permission to sell genetic tests for disease risks.

Thumbnail

Rheumatoid arthritis patients get moving, feel less fatigued when using pedometers

Providing rheumatoid arthritis patients with a simple pedometer has shown to increased daily activity and decrease fatigue, according to a study published in Arthritis Care & Research. 

PhRMA Launches New "Share the Savings" Campaign to Urge Payers to Share Negotiated Discounts with Patients

The Pharmaceutical Research and Manufacturers of America (PhRMA) today unveiled "Share the Savings," a new campaign to educate the public about the lack of rebate pass-through for commercially insured patients with high deductibles and coinsurance.

Displaying 1553 - 1560 of 2290

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup